Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.
U.S. consumers pay higher prices for weight loss drugs than any other country in the world, according to a 2023 KFF study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback